Peripheral Nerve Injury Market To Reach $2.58 Billion By 2030

March 2025 | Report Format: Electronic (PDF)

Peripheral Nerve Injury Market Growth & Trends

The global peripheral nerve injury market size is estimated to reach USD 2.58 billion by 2030, registering to grow at a CAGR of 7.80% from 2025 to 2030 according to a new report by Grand View Research, Inc. COVID-19 has had a negative impact on the market, affecting the demand and production directly, disrupting the supply chain, and increasing the financial burden on businesses. During the pandemic, a number of surgeries were regularly postponed and/or canceled to prevent the spread of COVID-19. Neurosurgical procedures decreased by 55% in the worst-hit countries, including the U.S., Russia, India, Brazil, France, the U.K., Italy, and Spain.

Furthermore, manufacturing activities, supply chain, delivery schedules, and sale of biomaterials were disrupted due to nationwide lockdowns. Moving forward, as industry players are introducing new and better technologies, the industry is expected to grow over the forecast period. For instance, in May 2022, the topline results of Clinical Study Axogen’s RECON comparing conduits to Avance Nerve Graft in digital nerve injuries were disclosed by Axogen, Inc., a global pioneer in marketing and developing revolutionary surgical solutions for PNIs. The primary target for the recovery of sensory function, as defined by static two-point discrimination, was fulfilled in Phase 3 pivotal research, and the safety profile was comparable with previously reported data. This information will help the company submit a Biologics License Application (BLA) in the second half of 2023.

key Request a free sample copy or view the report summary: Peripheral Nerve Injuries Market Report

Peripheral Nerve Injury Market Report Highlights

The nerve conduit led the market and accounted for a more than 64.30% revenue share in 2024.
The direct nerve repair segment led the market and accounted for more than 53.26% share of the global revenue in 2024.
The upper extremities segment accounted for the largest market share in 2024 and is anticipated to grow further at the fastest CAGR from 2025 to 2030.
North America held the largest revenue share of more than 30.43% in the market in 2024.